Innocan Pharma Corp (INNO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 8 | 12 | 11 | 9 | 10 |
| Income taxes - deferred | 64 | -262 | N/A | N/A | N/A |
| Accounts receivable | N/A | 0 | -754 | 288 | 466 |
| Accounts payable and accrued liabilities | 92 | 192 | -190 | 55 | -7 |
| Other Working Capital | 12 | 1,099 | -907 | 891 | 489 |
| Other Operating Activity | -682 | -1,622 | 1,862 | -557 | -590 |
| Operating Cash Flow | $-506 | $-581 | $22 | $686 | $368 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -6 | -4 | -1 | -5 |
| Other Investing Activity | 0 | 1 | 0 | -1 | 1 |
| Investing Cash Flow | $0 | $-5 | $-4 | $-2 | $-4 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 450 | N/A | N/A | N/A | N/A |
| Debt Issued | 0 | 0 | 0 | 0 | 640 |
| Debt Repayment | 0 | 0 | -3 | -4 | -4 |
| Common Stock Issued | N/A | 0 | 0 | 93 | 0 |
| Other Financing Activity | 0 | 0 | 0 | 64 | 360 |
| Financing Cash Flow | $450 | $0 | $-3 | $153 | $996 |
| Exchange Rate Effect | -4 | 3 | 0 | 53 | -3 |
| Beginning Cash Position | 6,687 | 7,270 | 7,255 | 6,365 | 5,008 |
| End Cash Position | 6,627 | 6,687 | 7,270 | 7,255 | 6,365 |
| Net Cash Flow | $-56 | $-586 | $15 | $837 | $1,360 |
| Free Cash Flow | |||||
| Operating Cash Flow | -506 | -581 | 22 | 686 | 368 |
| Capital Expenditure | N/A | -6 | -4 | -1 | -5 |
| Free Cash Flow | -506 | -587 | 18 | 685 | 363 |